J0895 – Injection, deferoxamine mesylate, 500 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0895
- Long description
- Injection, deferoxamine mesylate, 500 mg
- Short description
- Deferoxamine mesylate inj
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- Q0087
- Added
- January 1, 1992
- Last change
- January 1, 2001 – No change
Frequently asked questions
What is HCPCS code J0895?
J0895 is a HCPCS Level II code for injection, deferoxamine mesylate, 500 mg.
Does Medicare cover J0895?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0887 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888 – Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0889 – Daprodustat, oral, 1 mg, (for esrd on dialysis)
- J0890 – Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891 – Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892 – Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893 – Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894 – Injection, decitabine, 1 mg
- J0896 – Injection, luspatercept-aamt, 0.25 mg
- J0897 – Injection, denosumab, 1 mg
- J0898 – Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0899 – Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0900 – Injection, testosterone enanthate and estradiol valerate, up to 1 cc
- J0901 – Vadadustat, oral, 1 mg (for esrd on dialysis)
- J0911 – Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)
- J0945 – Injection, brompheniramine maleate, per 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.